UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cov2clusters: genomic clustering of SARS-CoV-2 sequences

BMC genomics, 2022-10, Vol.23 (1), p.1-710, Article 710

2022

Volltextzugriff (PDF)

Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study

Scientific reports, 2024-04, Vol.14 (1), p.8926-8926, Article 8926

2024

Volltextzugriff (PDF)

The mucoid switch in Pseudomonas aeruginosa represses quorum sensing systems and leads to complex changes to stationary phase virulence factor regulation

PloS one, 2014-05, Vol.9 (5), p.e96166-e96166

2014

Volltextzugriff (PDF)

Fosmidomycin decreases membrane hopanoids and potentiates the effects of colistin on Burkholderia multivorans clinical isolates

Antimicrobial agents and chemotherapy, 2014-09, Vol.58 (9), p.5211-5219

2014

Volltextzugriff (PDF)

Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis

PloS one, 2015-11, Vol.10 (11), p.e0143472-e0143472

2015

Volltextzugriff (PDF)

The Role of Mucoidy in Virulence of Bacteria from the Burkholderia cepacia Complex: A Systematic Proteomic and Transcriptomic Analysis

The Journal of infectious diseases, 2010-09, Vol.202 (5), p.770-781

2010

Volltextzugriff (PDF)

Differential Mucoid Exopolysaccharide Production by Members of the Burkholderia cepacia Complex

Journal of Clinical Microbiology, 2008-04, Vol.46 (4), p.1470-1473

2008

Volltextzugriff (PDF)

Long-Term Evolution of Burkholderia multivorans during a Chronic Cystic Fibrosis Infection Reveals Shifting Forces of Selection

mSystems, 2016-05, Vol.1 (3)

2016

Volltextzugriff (PDF)

Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.348-355

2016

Volltextzugriff (PDF)

In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients

Antimicrobial agents and chemotherapy, 2015-01, Vol.59 (1), p.711-713

2015

Volltextzugriff (PDF)

Presence of the Hmq System and Production of 4-Hydroxy-3-Methyl-2-Alkylquinolines Are Heterogeneously Distributed between Burkholderia cepacia Complex Species and More Prevalent among Environmental than Clinical Isolates

Microbiology spectrum, 2021-09, Vol.9 (1), p.e0012721

2021

Volltextzugriff (PDF)

Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence

Microbiology (Society for General Microbiology), 2011-11, Vol.157 (Pt 11), p.3124-3137

2011

Volltextzugriff (PDF)

In Vitro Susceptibility of Burkholderia vietnamiensis to Aminoglycosides

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2256-2264

2011

Volltextzugriff (PDF)

Burkholderia cepacia Complex Taxon K: Where to Split?

Frontiers in microbiology, 2020-07, Vol.11, p.1594-1594

2020

Volltextzugriff (PDF)

Phenotypic diversity and genotypic flexibility of Burkholderia cenocepacia during long-term chronic infection of cystic fibrosis lungs

Genome research, 2017-04, Vol.27 (4), p.650-662

2017

Volltextzugriff (PDF)

Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experience

Annals of the American Thoracic Society, 2015-01, Vol.12 (1), p.70-78

2015

Volltextzugriff (PDF)

Investigation of the physiological relationship between the cyanide-insensitive oxidase and cyanide production in Pseudomonas aeruginosa

Microbiology (Society for General Microbiology), 2006-05, Vol.152 (Pt 5), p.1407-1415

2006

Volltextzugriff (PDF)

Pseudomonas aeruginosa enhances production of a non-alginate exopolysaccharide during long-term colonization of the cystic fibrosis lung

PloS one, 2013-12, Vol.8 (12), p.e82621-e82621

2013

Volltextzugriff (PDF)

Swimming motility in a longitudinal collection of clinical isolates of Burkholderia cepacia complex bacteria from people with cystic fibrosis

PloS one, 2014-09, Vol.9 (9), p.e106428-e106428

2014

Volltextzugriff (PDF)

Mucoid and Nonmucoid Burkholderia cepacia Complex Bacteria in Cystic Fibrosis Infections

American journal of respiratory and critical care medicine, 2011, Vol.183 (1), p.67-72

2011

Volltextzugriff (PDF)

Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo

mBio, 2010-09, Vol.1 (4)

2010

Volltextzugriff (PDF)

Antibacterial Activity of a Natural Clay Mineral against Burkholderia cepacia Complex and Other Bacterial Pathogens Isolated from People with Cystic Fibrosis

Microorganisms (Basel), 2023-01, Vol.11 (1), p.150

2023

Volltextzugriff (PDF)

Bacteria of the Burkholderia cepacia complex are cyanogenic under biofilm and colonial growth conditions

BMC microbiology, 2008-06, Vol.8 (1), p.108-108, Article 108

2008

Volltextzugriff (PDF)

Epidemiology of Burkholderia Infections in People with Cystic Fibrosis in Canada between 2000 and 2017

Annals of the American Thoracic Society, 2020-12, Vol.17 (12), p.1549-1557

2020

Volltextzugriff (PDF)

Developing an international Pseudomonas aeruginosa reference panel

MicrobiologyOpen (Weinheim), 2013-12, Vol.2 (6), p.1010-1023

2013

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(53)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cov2clusters: genomic clustering of SARS-CoV-2 sequences

Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study

The mucoid switch in Pseudomonas aeruginosa represses quorum sensing systems and leads to complex changes to stationary phase virulence factor regulation

Fosmidomycin decreases membrane hopanoids and potentiates the effects of colistin on Burkholderia multivorans clinical isolates

Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis

The Role of Mucoidy in Virulence of Bacteria from the Burkholderia cepacia Complex: A Systematic Proteomic and Transcriptomic Analysis

Differential Mucoid Exopolysaccharide Production by Members of the Burkholderia cepacia Complex

Long-Term Evolution of Burkholderia multivorans during a Chronic Cystic Fibrosis Infection Reveals Shifting Forces of Selection

Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms

In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients

Presence of the Hmq System and Production of 4-Hydroxy-3-Methyl-2-Alkylquinolines Are Heterogeneously Distributed between Burkholderia cepacia Complex Species and More Prevalent among Environmental than Clinical Isolates

Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence

In Vitro Susceptibility of Burkholderia vietnamiensis to Aminoglycosides

Burkholderia cepacia Complex Taxon K: Where to Split?

Phenotypic diversity and genotypic flexibility of Burkholderia cenocepacia during long-term chronic infection of cystic fibrosis lungs

Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experience

Investigation of the physiological relationship between the cyanide-insensitive oxidase and cyanide production in Pseudomonas aeruginosa

Pseudomonas aeruginosa enhances production of a non-alginate exopolysaccharide during long-term colonization of the cystic fibrosis lung

Swimming motility in a longitudinal collection of clinical isolates of Burkholderia cepacia complex bacteria from people with cystic fibrosis

Mucoid and Nonmucoid Burkholderia cepacia Complex Bacteria in Cystic Fibrosis Infections

Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo

Antibacterial Activity of a Natural Clay Mineral against Burkholderia cepacia Complex and Other Bacterial Pathogens Isolated from People with Cystic Fibrosis

Bacteria of the Burkholderia cepacia complex are cyanogenic under biofilm and colonial growth conditions

Epidemiology of Burkholderia Infections in People with Cystic Fibrosis in Canada between 2000 and 2017

Developing an international Pseudomonas aeruginosa reference panel

Suchergebnisse filtern